Research reportIncreased amphetamine-induced locomotion during inactivation of the basolateral amygdala
Section snippets
Subjects
Twenty-five male albino Sprague–Dawley rats (Charles River Laboratories, Wilmington, MA), weighing between 300 and 325 g, were individually housed in plastic tub cages (with paper shavings as bedding). The cages were located within a temperature-controlled (23 °C ) vivarium on a 12 h/12 h dark/light cycle (lights on at 07:00 h). Subjects had ad libitum access to food (Purina Rat Chow) and water throughout the course of the experiment. Each animal was gentled through handling for approximately 15 min
Results
Fig. 1 illustrates the range of cannula placements and confirms the BLA as the target site for the lidocaine infusions. Fig. 2 depicts the effect of inactivation of the BLA (IC lidocaine injections) on spontaneous locomotor activity. A two-way (Time×Group) ANOVA (using Time as a repeated measure) performed on the data from Fig. 2 confirmed the absence of any Group effect (F(1,17)=3.077, P>0.05), nor a Group×Time interaction (F(5,85)=0.301, P>0.05). The analysis revealed a significant effect of
Discussion
The data from the current experiment show that while a temporary lesion of the BLA had no effect on spontaneous locomotor activity, it enhanced the locomotor response to amphetamine. Other researchers have found similar results with BLA lesions differentially affecting spontaneous versus novelty- or amphetamine-induced locomotor activity. In results that parallel those of the present experiment, 6-OHDA lesions of the BLA had no effect on spontaneous locomotor activity, whereas the same lesions
Acknowledgements
Support for this study was provided by an NIDA grant DA-05041 awarded to A.E. The author would like to thank Drs. Mary Raven and Osnat Ben-Shahar for their invaluable advice and guidance, and Aaron Kornblith, Rhasson Ager, and Rick Bernardi for their assistance in the testing of subjects. Special thanks to Stephanie Richardson for her help with the histological analyses and to Dr. Wayne Brake for comments on an earlier version of this manuscript.
References (49)
- et al.
d-Amphetamine, cocaine, and caffeine: a comparative study of acute effects on locomotor activity and behavioral patterns in rats
Neurosci. Biobehav. Rev.
(1998) - et al.
Differential effects of excitotoxic lesion of the basolateral amygdala, ventral subiculum, and medial prefrontal cortex on responding with conditioned reinforcement and locomotor activity potentiated by intra-accumbens infusions of d-amphetamine
Behav. Brain Res.
(1993) - et al.
The pharmacological and anatomical substrates of the amphetamine response in the rat
Brain Res.
(1975) - et al.
Input from the amygdala to the rat nucleus accumbens: its relationship with tyrosine hydroxylase immunoreactivity and identified neurons
Neuroscience
(1994) - et al.
The amygdalostriatal projection in the rat—an anatomical study by anterograde and retrograde tracing methods
Neuroscience
(1982) - et al.
Selective 6-OHDA-induced destruction of mesolimbic dopamine neurons: abolition of psychostimulant-induced locomotor activity in rats
Eur. J. Pharmacol.
(1976) - et al.
Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum
Brain Res.
(1975) - et al.
In vivo measures of monamines during amphetamine-induced behaviors in rats
Prog. Neuropsychopharmacol. Biol. Psychiatry
(1990) The advantages and limitations of permanent or reversible deactivation techniques in the assessment of neural function
J. Neurosci. Methods
(1999)- et al.
Modulation of dopaminergic activity in the nucleus accumbens following facilitation or blockade of the dopaminergic transmission in the amygdala: a study by in vivo differential pulse voltometry
Brain Res.
(1985)
Mesolimbic dopaminergic system activity as a function of food reward: a microdialysis study
Pharmacol. Biochem. Behav.
Autoradiographic estimation of the extent of reversible inactivation produced by microinjection of lidocaine and muscimol in the rat
Neurosci. Lett.
Lesions of the basolateral amygdala abolish the ability of drug associated cues to reinstate responding during withdrawal from self-administered cocaine
Behav. Brain Res.
Behavioral effects of psychomotor stimulant infusions into amygdaloid nuclei
Neuropsychopharmacology
Role of noradrenergic and dopaminergic processes in amphetamine self-administration
Pharmacol. Biochem. Behav.
Lesion of dopaminergic terminals in the amygdala produces enhanced locomotor response to d-amphetamine and opposite changes in dopaminergic activity in prefrontal cortex and nucleus accumbens
Brain Res.
Effects of basolateral amygdala dopamine depletion on the nucleus accumbens and medial prefrontal cortex dopmaine response to stress
Neuroscience
Effective spread and time course of neural inactivation caused by lidocaine injection in monkey cerebral cortex
J. Neurosci. Methods
In vitro and in vivo effects of cocaine and selected local anesthetics on the dopamine transporter
Eur. J. Pharmacol.
Reinforcing properties of some local anesthetics in rhesus monkeys
Pharmacol. Biochem. Behav.
Neurobiology of cocaine abuse
Trends in Pharmacol. Sci.
Mesolimbic dopamine projection modulates amygdala-evoked excitatory postsynaptic potentials in nucleus accumbens neurons: an in vivo study
Brain Res.
The effects of excitotoxic lesions of the basolateral amygdala on the acquisition of heroin-seeking behavior in rats
Psychopharmacology
Effect of dietary lipid on locomotor activity and response to psychomotor stimulants
Psychopharmacology
Cited by (15)
Differential and long-lasting changes in neurotransmission in the amygdala of male Wistar rats during extended amphetamine abstinence
2022, NeuropharmacologyCitation Excerpt :Even though expression of behavioral sensitization is primarily associated with dopaminergic neurotransmission in the nAc, the amygdala may play a role during the induction of sensitization (Kalivas and Alesdatter, 1993; Wolf et al., 1995). In fact, while inactivation of the BLA has no effect on basal locomotor activity, it potentiates amphetamine-induced hyperactivity (Woods and Ettenberg, 2004). Activation of the BLA, on the other hand, decreases amphetamine-induced locomotor activity (Lai and Chang, 2019).
Differential implication of dorsolateral and dorsomedial srtiatum in encoding and recovery processes of latent inhibition
2014, Neurobiology of Learning and MemoryCitation Excerpt :Lidocaine 2% (Sigma Aldrich) was delivered at a rate of 0.25 μl per min for 2 min, with a total volume of 0.5 μl per side. Previous studies in our lab and several works have employed lidocaine successfully with similar doses (Waraczynski, 2003; Woods & Ettenberg, 2004). This volume produces neuronal inhibition for around 30 min, and the spherical boundary surrounding the infusion cannula tip is estimated with a radius of 0.5 mm (Lomber, 1999).
Behavioral changes and brain energy metabolism dysfunction in rats treated with methamphetamine or dextroamphetamine
2012, Neuroscience LettersCitation Excerpt :AMPHs and other psychostimulants induce profound behavioral activation in rats, mice, and other animals used in the psychopharcological studies, such as increased locomotion, rearing, and sniffing behavior. Locomotor activating effects of AMPH are dependent on the nucleus accumbens [34], although the degree of activity is mediated by regulatory regions outside of the NAc, including the hippocampus [48], the amygdala [49], and the medial prefrontal cortex [20]. An additional element observed in this study was that both m-AMPH and d-AMPH at 2 mg/kg increased the number of visits to the center of the open-field, showing the equivalence of the two drugs to induce risk-taking behavior in rats.
Heightened locomotor-activating effects of amphetamine administered into the nucleus accumbens in adolescent rats
2011, International Journal of Developmental NeuroscienceInactivation of the medial preoptic area/anterior hypothalamus by lidocaine reduces male sexual behavior and sexual incentive motivation in male rats
2008, NeuroscienceCitation Excerpt :Half of the animals were injected with saline (2 μl per cannula) and the other half with lidocaine (40 μg in 2 μl of saline per cannula). This lidocaine dose is within the range usually employed in behavioral studies (Woods and Ettenberg, 2004; Broadbent et al., 2006). At infusions the injector was placed into the guide cannula 5 min before starting drug or saline administration.